N
Naifei Chen
Researcher at Jilin University
Publications - 35
Citations - 815
Naifei Chen is an academic researcher from Jilin University. The author has contributed to research in topics: Internal medicine & Medicine. The author has an hindex of 10, co-authored 26 publications receiving 397 citations. Previous affiliations of Naifei Chen include VA Palo Alto Healthcare System.
Papers
More filters
Journal ArticleDOI
A novel FLI1 exonic circular RNA promotes metastasis in breast cancer by coordinately regulating TET1 and DNMT1
Naifei Chen,Gang Zhao,Xu Yan,Zheng Lv,Hongmei Yin,Shilin Zhang,Shilin Zhang,Wei Song,Xueli Li,Xueli Li,Lingyu Li,Zhonghua Du,Lin Jia,Lin Jia,Lei Zhou,Wei Li,Andrew R. Hoffman,Ji-Fan Hu,Ji-Fan Hu,Jiuwei Cui +19 more
TL;DR: Data suggest that FECR1 circular RNA acts as an upstream regulator to control breast cancer tumor growth by coordinating the regulation of DNA methylating and demethylating enzymes.
Journal ArticleDOI
Mechanisms of Cancer Resistance to Immunotherapy.
TL;DR: Mechanisms of cancer immunotherapy resistance including tumor-intrinsic factors and tumor-extrinsics factors are discussed, which can improve the quality of medical care for cancer diagnosis and treatment, which improve thequality of life of patients, and finally lead to accurate individualized treatment.
Journal ArticleDOI
Prognostic value of MICA/B in cancers: a systematic review and meta-analysis
Yijing Zhao,Naifei Chen,Yu Yu,Lili Zhou,Chao Niu,Yudi Liu,Huimin Tian,Zheng Lv,Fujun Han,Jiuwei Cui +9 more
TL;DR: Serum soluble MICA/B represents a potential prognostic marker in various human cancers and was found associated with increased survival in patients with cancers of the digestive system.
Journal ArticleDOI
Neoadjuvant and Adjuvant Immunotherapy: Opening New Horizons for Patients With Early-Stage Non-small Cell Lung Cancer.
TL;DR: This review focuses on the research progress of clinical trials of neoadjuvant and adjuvant therapy with ICIs in early-stage NSCLC, the exploration of response evaluation and predictive biomarkers, and the urgent problems to be solved in the future.
Journal ArticleDOI
Nerves in the Tumor Microenvironment: Origin and Effects.
TL;DR: In this article, a review describes the evolving cross-talk between nerves and cancer cells, thus uncovers potential therapeutic targets for cancer, and points to the potential utility of anti-neurogenic therapies.